RCGP highlights dangers of antibiotics for children when not ‘absolutely necessary’
30% of antibiotics prescribed in outpatient settings in the US, and between 9% and 23% in UK primary care are unnecessary.
13th August 2019
Latest news
Novel chlamydia vaccine proves safe in early trial
The positive safety results show that the experimental treatment could become a promising early candidate for a chlamydia vaccine.
13th August 2019
NHS strengthens Long Term Plan with digital diabetes prevention roll-out
Almost seven in 10 people referred to digital schemes took part compared with around half of those offered face-to-face support.
13th August 2019
SMC rejects Orkambi, accepts four medicines
The rejection was due to ‘uncertainties in the company’s evidence about the long term health benefits of both medicines in relation to their costs.'
13th August 2019
Asthma deaths ‘highest this decade’
Professor Helen Stokes-Lampard, chair of the Royal College of GPs said the figures are “deeply concerning”.
12th August 2019
Average GP waiting times now ‘exceed two weeks’
Data from a new report show that the waiting times now exceed a fortnight, for the first time ever.
12th August 2019
Tremfya tops Cosentyx in late-stage study
The study is the first to compare Tremfya and the IL-17 inhibitor, Cosentyx.
12th August 2019
LIVI announces new NHS partnerships
Video consultations have been cited as a way to take the strain off GPs.
12th August 2019
NICE highlights need for more cannabis-based research
NHS England has also published a review aimed at assessing the barriers to prescribing cannabis-based medicinal products.
12th August 2019
Latest performance stats show NHS is 'struggling'
The number of A&E patients in England waiting on trolleys for more than four hours is the highest since records began.
9th August 2019
Ipsen launches new self-injection Somatuline option
Good news for adult patients with gastroenteropancreatic neuroendocrine tumours.
9th August 2019
Bayer acquires BlueRock in cell therapy move
After the acquisition, Bayer will own full rights to BlueRock Therapeutics’ CELL+GENE platform.
9th August 2019
NHS publishes list of suppliers to boost purchasers’ confidence
The organisations have developed a new section on the Health Systems Support Framework.
9th August 2019
AZ’ Tagrisso improves overall survival in lung cancer
The trial previously met its primary endpoint in July 2017, showing a statistically-significant and clinically-meaningful improvement in progression-free survival.
9th August 2019
Five-year framework for community pharmacy funding announced
The framework agreement for community pharmacies announced funding of almost £13 billion over five years.
8th August 2019
